• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study.

作者信息

Gamba G, Solerte S B, Grignani G, Pacchiarini L, Montani N, Ferrari E

机构信息

Department of Internal Medicine and Medical Therapy, University of Pavia, Italy.

出版信息

Blut. 1988 Jun;56(6):257-60. doi: 10.1007/BF00320285.

DOI:10.1007/BF00320285
PMID:3382760
Abstract

The relationship among blood lipids, haemostatic and fibrinolytic parameters have been evaluated, during a follow-up study, in 27 non-insulin dependent (type II) diabetic patients. Upon recruitment, and in periodical controls, we observed that plasma triglycerides and VLDL levels correlated inversely, and HDL directly, with the fibrinolytic activity of plasma and euglobulin precipitate. Furthermore triglycerides and VLDL correlated directly with Factor VIII antigen (vWFAg). After 5 years in the study, 12 patients (44%) had macroangiopathic complications, and 9 of these subjects showed persistently high levels of triglycerides (above 2.36 mmol/l). These haemostatic and lipid components, however, do not influence the progression of diabetic retinopathy and nephropathy. The alterations of lipid, haemostatic and fibrinolytic parameters and their possible relationships seem to play an important role in the occurrence of diabetic macroangiopathy.

摘要

相似文献

1
Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study.
Blut. 1988 Jun;56(6):257-60. doi: 10.1007/BF00320285.
2
Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.伴有和不伴有糖尿病血管并发症的2型糖尿病患者的凝血和纤维蛋白溶解参数。
Med Princ Pract. 2005 Jan-Feb;14(1):22-30. doi: 10.1159/000081919.
3
Hypofibrinolysis associated with vasculopathy in non insulin dependent diabetes mellitus.
Thromb Res. 1990 Jul 1;59(1):51-9. doi: 10.1016/0049-3848(90)90270-m.
4
Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.2型糖尿病患者血浆尾加压素II水平升高与糖尿病视网膜病变及颈动脉粥样硬化相关。
Clin Sci (Lond). 2008 Dec;115(11):327-34. doi: 10.1042/CS20080014.
5
[Diabetes mellitus and fibrinolysis (experience with an in vitro clot lysis test)].[糖尿病与纤维蛋白溶解(体外血块溶解试验的经验)]
Orv Hetil. 1994 Sep 11;135(37):2025-7.
6
Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.口服避孕甾体激素对动脉血栓形成生化标志物的药效学作用。非糖尿病女性和胰岛素依赖型糖尿病女性的研究。
Dan Med Bull. 2002 Feb;49(1):43-60.
7
Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.2型糖尿病伴或不伴大血管病变患者的血清内脂素及其与胰岛素抵抗和炎症的关系。
Saudi Med J. 2008 Feb;29(2):185-92.
8
[Hemostasis and lipid metabolism in patients with non-insulin- dependent diabetes mellitus and angiopathy of the lower extremities].非胰岛素依赖型糖尿病合并下肢血管病变患者的止血与脂质代谢
Klin Med (Mosk). 1989 Aug;67(8):74-6.
9
Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.亚临床甲状腺疾病中的血液凝固、纤溶活性和血脂谱:亚临床甲状腺功能亢进会增加血浆凝血因子X活性。
Clin Endocrinol (Oxf). 2006 Mar;64(3):323-9. doi: 10.1111/j.1365-2265.2006.02464.x.
10
[Lipid metabolism and fibrinolysis in diabetic nephropathy in the course of diabetes type II].[2型糖尿病病程中糖尿病肾病的脂质代谢与纤维蛋白溶解]
Pol Arch Med Wewn. 1995 Oct;94(4):324-30.

本文引用的文献

1
Vascular disease and serum lipids in diabetes mellitus. Observations over thirty years (1931-1961).糖尿病中的血管疾病与血脂。三十年(1931 - 1961年)观察
Ann Intern Med. 1963 Feb;58:305-23. doi: 10.7326/0003-4819-58-2-305.
2
The determination of plasma fibrinogen by the clot-weight method.用凝块重量法测定血浆纤维蛋白原。
Biochem J. 1952 Aug;51(5):583-5. doi: 10.1042/bj0510583.
3
Effect of cholesterol on production of thromboxane b2 by platelets in vitro.胆固醇对体外血小板血栓素B2生成的影响。
N Engl J Med. 1980 Jan 3;302(1):6-10. doi: 10.1056/NEJM198001033020102.
4
Glucose inhibits replication of cultured human endothelial cells.葡萄糖抑制培养的人内皮细胞的复制。
Diabetologia. 1982 Nov;23(5):436-9. doi: 10.1007/BF00260958.
5
Hematologic alterations in diabetes mellitus.糖尿病中的血液学改变。
Am J Med. 1981 Feb;70(2):339-52. doi: 10.1016/0002-9343(81)90771-3.
6
In vitro injury of porcine aortic endothelial cells by very-low-density lipoproteins from diabetic rat serum.糖尿病大鼠血清极低密度脂蛋白对猪主动脉内皮细胞的体外损伤
Diabetes. 1982 Jul;31(7):593-9. doi: 10.2337/diab.31.7.593.
7
Enhanced antithrombotic mechanisms in patients with maturity-onset diabetes mellitus without thromboembolic complications.无血栓栓塞并发症的成年发病型糖尿病患者的抗血栓形成机制增强。
Thromb Haemost. 1981 Oct;46(3):648-51.
8
Fibrinogen as a risk factor for stroke and myocardial infarction.纤维蛋白原作为中风和心肌梗死的一个风险因素。
N Engl J Med. 1984 Aug 23;311(8):501-5. doi: 10.1056/NEJM198408233110804.
9
Activators and inhibitors of the fibrinolytic system in maturity-onset diabetes mellitus without thromboembolic manifestations.无血栓栓塞表现的成年型糖尿病患者纤溶系统的激活剂和抑制剂
Ric Clin Lab. 1983 Jul-Sep;13(3):337-45. doi: 10.1007/BF02905877.
10
Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations.糖尿病对脂蛋白甘油三酯和胆固醇浓度影响的性别差异。
N Engl J Med. 1984 Oct 11;311(15):953-9. doi: 10.1056/NEJM198410113111505.